Appointment New Patient Appointment or 214-645-8300

MedBlog

Search Results

Results: Articles

Cancer; Kidneys

New immunotherapy can prevent kidney cancer recurrence after surgery: Is it right for you?

The FDA has approved pembrolizumab immunotherapy, the first treatment to lower kidney cancer recurrence risk after surgery. UT Southwestern's Dr. Hans Hammers helps patients explore its benefits and risks.

COVID; Discovery

COVID-19 and me: A global pandemic gets personal

UT Southwestern's Claire Aldridge was plunged headfirst into the COVID-19 pandemic when she and her family contracted the virus in early March. She shares her experience battling the novel coronavirus and then donating her plasma in hopes of helping others.

Cancer; Discovery; Patient Stories

Immunotherapy and the marathon against melanoma: Terry's story

Immunotherapy has dramatically improved melanoma survival rates. In this week's MedBlog, Terry Hart tells his story of surviving advanced melanoma through immunotherapy.

COVID; Discovery

Searching for the Holy Grail of COVID-19

The world’s scientists and physicians, including many of at UT Southwestern, have rallied together to conduct clinical trials and research around COVID-19. David Greenberg, M.D., an infectious and geographic medicine expert, shares recent discoveries and offers a glimpse at what a vaccine might look like.

Cancer; Dermatology

3 skin cancer treatments that might stop melanoma in its tracks

Melanoma rates are increasing in the U.S., even as incidences of other cancers are declining. However, treatment advances in the last decade have tripled survival rates for advanced melanoma.

Prevention; Your Pregnancy Matters

Allergic to penicillin? There’s a 90% chance that’s not true

More than 90 percent of patients who believe they are allergic to penicillin actually aren’t. This is a serious concern, particularly during pregnancy. In this week’s Your Pregnancy Matters blog, allergy expert David Khan, M.D., discusses penicillin allergy testing and antibiotic safety.